Action:
Implementaton of 2020 legislation
General Information
| Action Summary |
The action will amend the requirements for documented informed consent by a patient for participation in a collaborative practice agreement between a prescriber and a pharmacist. The amendment will conform to changes made in HB1506 of the 2020 General Assembly that specifies a patient must opt out of participation rather than signing a document for consent to such an agreement. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
ยง 2.2-4006 (A) (4)(a)
|
| RIS Project |
Yes [006506] |
| Associated Mandates |
Collaborative practice agreements
|
| New Periodic Review |
This action will be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
9078
|
Final
|
Stage complete. This regulation became effective on 11/25/2020. |
Contact Information
|
Name / Title:
|
Caroline Juran, RPh
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
|
|
Email Address:
|
caroline.juran@dhp.virginia.gov
|
|
Phone:
|
(804)367-4456
FAX: (804)527-4472
TDD: ()-
|
This person is the primary contact for this chapter.
